The purpose of result matched startPRODresult matched end is to improve firms’ product oversight and governance processes and to set out the FCA’s statement of policy on making temporary product intervention rules.
PROD 1 Product Intervention and Product Governance Sourcebook (PROD)
PROD 1.1 Application and purpose
Purpose
Product oversight and governance refers to the systems and controls firms have in place to design, approve, market and manage products throughout the products’ lifecycle to ensure they meet legal and regulatory requirements.
Good product governance should result in products that:
- (1)
meet the needs of one or more identifiable target markets;
- (2)
are sold to clients in the target markets by appropriate distribution channels; and
- (3)
deliver appropriate client outcomes.
Unless the contrary intention appears, a reference to Gibraltar-based firm in result matched startPRODresult matched end has the same meaning as in the Gibraltar Order.
PROD 1.2 Application of PROD 2
PROD 2 sets out the FCA’s approach to issuing temporary product intervention rules. It is of relevance to all firms.
PROD 1.3 Application of PROD 3
General: Who? What?
PROD 3 applies to
- (1)
- (2)
- (3)
- (4)
-
with respect to:
- (5)
manufacturing financial instruments and structured deposits; and
- (6)
distributing financial instruments, structured deposits and investment services.
[Note: articles 1(3), 1(4), 16(3), 24(2) and 41(2) of MiFID]
A TP firm and a Gibraltar-based firm must also comply with the provisions in PROD 1.3 and PROD 3 in relation to a pathway investment, with respect to activities carried on from an establishment maintained by it, or its appointed representative, in the United Kingdom.
Other firms manufacturing or distributing financial instruments or structured deposits
- (1)
Subject to (2) other firms which manufacture or distribute financial instruments or structured deposits should take account of PROD 3 as if it were guidance on the Principles and other relevant rules and as if “should” appeared in PROD 3 rules instead of “must”.
- (2)
Paragraph (1) does not apply to a firm to the extent that it is required to comply with Principle 12 (Consumer Duty) and PRIN 2A in relation to a product.
Eligible counterparty business
PROD 3.3.1R does not apply to eligible counterparty business.
[Note: article 30(1) of MiFID]
Plain vanilla listed bond
PROD 3.2.19RtoPROD 3.2.26Rdo not apply in respect of the manufacture of plain vanilla listed bonds issued by an ESCC issuer or ESCC subsidiary.
Where?
PROD 3 applies to a firm with respect to activities carried on from an establishment maintained by it, or its appointed representative, in the United Kingdom.
- (1)
PROD 3 also applies to a firm with respect to activities from an establishment overseas with a client in the United Kingdom.
- (2)
But PROD 3 does not apply to those activities if the office from which the activity is carried on were a separate person and the activity:
- (a)
would fall within the overseas persons exclusions in article 72 of the Regulated Activities Order; or
- (b)
would not be regarded as being carried on in the United Kingdom.
- (a)
MiFID
PERG 13 contains general guidance on the meaning of financial instrument, investment services and/or activities and MiFID investment firm (and of certain other kinds of investment firm).
Manufacturing pathway investments and default options
A firm that is within the scope of PROD 3 (Product governance: MiFID) when it manufactures pathway investments or default options other than in connection with its operating of a retail client’s personal pension scheme or stakeholder pension scheme, is also subject to PROD 6 (Product governance: additional provisions for pathway investments and default options) as guidance with respect to that manufacturing activity (see PROD 1.6.1R(3)).
Application to a public offer platform operator
- (1) A POP operator is a distributor for the purposes of PROD 3 and must comply with PROD 3 to the extent that it is within the scope of PROD 1.3.1R.
- (2) Where a POP operator's activity is not within the scope of PROD 1.3.1R, it must comply with the requirements in Principle 12 and PRIN 2A.
PROD 1.4 Application of PROD 4
PROD 4 applies to:
- (1)
an insurance intermediary; and
- (2)
an insurer,
with respect to:
- (3)
manufacturing insurance products;
- (3A)
product governance and distribution arrangements for legacy non-investment insurance products (see PROD 4.6); and
- (4)
distributing insurance products.
[Note: articles 1(2) and 25 of the IDD]
A TP firm and a Gibraltar-based firm must also comply with the provisions in:
- (1)
PROD 1.4 and PROD 4.5 (Additional expectations for manufacturers and distributors in relation to value measures data);
- (2)
PROD 1.4 and PROD 4 in relation to a pathway investment;
- (3)
PROD 1.4, PROD 4 and (where applicable) PROD TP 1 in relation to non-investment insurance products (including legacy non-investment insurance products) that are, or will be, marketed or distributed, or there are policies under the product that remain in force, in the United Kingdom.
PROD 4.5 (Additional expectations for manufacturers and distributors in relation to value measures data) applies regardless of when the product was first manufactured.
In result matched startPRODresult matched end an insurance product may be read as being a reference to the product for distribution to customers generally and is not intended to refer to each individual contract of insurance being sold or underwritten (unless the context indicates otherwise).
PROD 4 does not apply in relation to an insurance product that is:
- (1) (a) a specialist risks contract; or
- (b) a general insurance contract (other than a specialist risks contract) distributed to larger commercial customers who make the arrangements preparatory to them concluding the contract of insurance (directly or through an agent),
- which meets the conditions in PROD 1.4.3-AR;
- (2) a reinsurance contract; or
- (3) a bespoke insurance contract within the meaning of PROD 1.4.3-CR.
The conditions in PROD 1.4.3R(1) are that the insurance product is used exclusively for effecting the types of contract set out in PROD 1.4.3R(1)(a) or (b) where there are no:
(1)
policyholder(s); or
(2)
(where relevant) policy stakeholders, including, in relation to a multi-occupancy building insurance contract, any leaseholder,
who in that context are natural persons acting for purposes outside of their trade, business or profession.
The effect of PROD 1.4.3AR(1)(b) and PROD 1.4.3-AR is that PROD 4 will not apply to general insurance contracts (other than specialist risks contracts) where the policyholder who makes the arrangements preparatory to the conclusion of the contract is a larger commercial customer and all the other policyholders and any policy stakeholders are commercial customers. Therefore PROD 4 will apply if at least one of the policyholders or any policy stakeholders is a consumer.
Bespoke insurance contracts
- (1) A bespoke insurance contract in PROD 1.4.3R(3) is a non-investment insurance contract where the requirements in (2) are met, and either:
- (a) it is an adaptation of one of the firm's existing insurance products beyond what the existing product covers; or
- (b) it is a new contract of insurance that has been created by the firm and not adapted from the firm's existing insurance products.
- (2) A contract in (1) is only a bespoke insurance contract if:
- (a) the firm adapts or creates it solely and specifically for, and in response to the request of, a customer, in order to meet that customer's particular insurance needs, objectives, interests and/or characteristics, where those needs, objectives, interests or characteristics cannot currently be met by the firm's existing insurance products (unless adapted); and
- (b) the firm does not market it or offer it as available to any other customers.
- (1) Reference to what the existing product covers in PROD 1.4.3-CR(1)(a) includes:
- (a) different variants of the product and any optional extras or extended cover generally offered with or part of the existing product. A contract resulting from an adaptation of an existing product to give effect to choices by selecting from those variants, optional extras or that extended cover, is not a bespoke contract; and
- (b) situations where insurers amend contracts to include conditions, restrictions or provisions (by endorsement or otherwise) to address particular risks arising in relation to a particular customer, and which risks could also apply to others within the existing target market. This only applies where it can reasonably be said that the cover as amended falls within the same general scope of cover envisaged by the existing product. For example, a home insurer may impose a condition in relation to the locks required to ensure cover in a particular post code area considered by the insurer to present higher risks.
- (2) Reference to ‘on the request of a customer’ also includes where requests are made by agents with the appropriate authority of the customer – for example, an insurance intermediary who, on behalf of the customer, approaches the insurer and negotiates the terms of the bespoke insurance contract.
- (3) A firm marketing itself in general terms as having specialist expertise in a particular field,for example, that on request the firm can consider bespoke products in relation to adventurous or hazardous sport activities, is not the kind of marketing envisaged in PROD 1.4.3.-CR(2)(b).
- (4) An existing insurance product referred to in PROD 1.4.3-CR is a product manufactured by the firm in line with PROD 4.2.
As long as it meets the requirements set out in PROD 1.4.3-CR:
- (1) a bespoke insurance contract can be used again if other customer approach the firm for similar insurance cover without that use leading to the contract being considered an ‘insurance product’ for the purposes of PROD 4. However, in order to meet the requirements in PROD 1.4.3-CR the firm will need to be satisfied that the customer's approach does not result from the marketing or other offer by that firm to potential customers of the availability from the firm of that type of similar insurance cover (however small the target market or group of customers might be); and
- (2) a contract that has been specifically created by a firm (PROD 1.4.3-CR(1)(b)) can contain existing insurance product wording.
Manufacturing and distributing pathway investments and default options
A firm that is within the scope of PROD 4 (Product governance: IDD) when itmanufactures pathway investments or default options other than in connection with its operating of a retail client’s personal pension scheme or stakeholder pension scheme, is also subject to PROD 6 (Product governance: additional provisions for pathway investments and default options) as guidance with respect to that manufacturing activity (see PROD 1.6.1R(2)).
Where a firm:
- (1)
manufactures or distributes pathway investments or default options in connection with its operating of a retail client’s personal pension scheme or stakeholder pension scheme; and
- (2)
is not otherwise within the scope of the rules in result matched startPRODresult matched end in relation to that manufacturing or distribution activity, then PROD 4, PROD 1.4.4R and PROD 1.4.10G apply with respect to that manufacturing or distribution activity.
The effect of PROD 1.4.3BR is to apply PROD 4 to any firm, such as a SIPP operator, which:
- (1)
manufactures or distributes pathway investments or default options in connection with its operating of a retail client’s personal pension scheme or stakeholder pension scheme; and
- (2)
before the entry into force of PROD 1.4.3BR, was not subject to the rules or onshored regulations in result matched startPRODresult matched end.
When an intermediary may be considered to be manufacturing
(1)
For the purposes of PROD 4, an insurance intermediary will be considered a manufacturer where an overall analysis of their activity shows that it has a decision-making role in designing and developing an insurance product for the market.
(2)
For the purposes of (1), a decision-making role must be assumed, in particular, where an insurance intermediary autonomously determines the essential features and main elements of an insurance product, including its coverage, price, costs, risk, target market and compensation and guarantee rights, which are not substantially modified by the insurance undertaking providing coverage for the insurance product.
(3)
[deleted]
[Note: article 3 of the IDD POG Regulation]
The effect of PROD 1.4.4R and PROD 1.4.6R is that an insurance intermediary needs to consider if it is manufacturing an insurance product or if it would be a manufacturer for a legacy non-investment insurance product for PROD 4.6, and, if so, should comply with PROD 4.2 (Manufacture of insurance products).
Scope of ‘manufacturing’
- (1)
PROD 4.2 applies to firms that manufacture insurance products. The terms ‘firm’ and ‘manufacturer’ are used in that section interchangeably to refer to such persons.
- (2)
The Glossary term ‘manufacture’ includes ‘designing, developing, creating and/or underwriting’ which cover activities prior to the insurance product being approved for marketing and distribution, and on a continuing basis after such approval.
[deleted]
Effect and interpretation of PROD 1.4 and PROD 4 for certain manufacturers and distributors of pathway investments and default options
A firm to which PROD 1.4.3BR applies must
(1)
[deleted]
(2)
read terms or phrases found in PROD 1.4 or PROD 4 as follows:
(a)
terms referred to in column (1) of the table below have the meaning indicated in the same row of column (2) of the table;
(b)
terms relating to insurance or insurance products have the meaning of the corresponding term relevant in the context of pathway investments or default options; and
(c)
terms or phrases which are only relevant to firms manufacturing or distributing insurance products may be disregarded.
This table belongs to PROD 1.4.6AR(2)(a).
| (1) | (2) |
|---|---|
| “insurance-based investment products” | pathway investment or default option |
| “insurance product” | pathway investment or default option |
| “premiums” | costs and charges |
Where?
PROD 4 applies to a firm with respect to activities carried on from an establishment maintained by it, or its appointed representative:
- (1)
(for all insurance products and pathway investments) in the United Kingdom; and
- (2)
(in addition, for non-investment insurance products) overseas, in relation to an insurance product that is, or will be, marketed or distributed, or there are policies under the product that remain in force, in the United Kingdom.
[Note: in respect of (1), article 7(2) of the IDD]
Modification of PROD 4.2 and PROD 4.3 for overseas non-investment insurance products
PROD 4 applies in relation to an overseas non-investment insurance product with the following modifications:
- (1)
The changes made to PROD 4.2 and PROD 4.3 in Annex E of the Non-Investment Insurance: Product Governance, Premium Finance, General Insurance Auto-renewal and Home and Motor Insurance Pricing Instrument 2021 do not apply, unless otherwise specified in (2).
- (2)
The following rules and guidance in Annex E of the Non-Investment Insurance: Product Governance, Premium Finance, General Insurance Auto-renewal and Home and Motor Insurance Pricing Instrument 2021 continue to apply:
- (a)
- (b)
- (c)
PROD 4.2.34AG; and
- (d)
[Note: the Non-Investment Insurance: Product Governance, Premium Finance, General Insurance Auto-renewal and Home and Motor Insurance Pricing Instrument 2021 can be found at [/instrument/2021/FCA_2021_19.pdf]]
- (1)
The effect of PROD 1.4.11R is that, for an overseas non-investment insurance product, including where this is a legacy non-investment insurance product subject to PROD 4.6, a firm’s product approval process (and arrangements for ongoing monitoring) need only comply with:
- (a)
the requirements in PROD 4.2 or PROD 4.3 as they stood on 30 September 2021, except for those provisions in PROD 1.4.11R(2); and
- (b)
any subsequent changes made by an instrument other than the Non-Investment Insurance: Product Governance, Premium Finance, General Insurance Auto-renewal and Home and Motor Insurance Pricing Instrument 2021.
PROD 1.4 and PROD 4 as it stood on 30 September 2021 can be accessed by using the timeline on the FCA Handbook website. Firms will need to consider any further changes to result matched startPRODresult matched end after this date to consider if they apply in relation to overseas non-investment insurance products.
- (a)
- (2)
A non-investment insurance product:
- (a)
that will be or is available for distribution or marketing to customers who are habitually resident or, if applicable, where the state of the risk is, in the United Kingdom; or
- (b)
where, for any policy issued under the product, the policyholder is habitually resident in or, if applicable, the state of the risk is in, the United Kingdom,
will not be an overseas non-investment insurance product and the firm will need to meet all applicable requirements in PROD 4 including PROD 4.2.14AR in relation to providing fair value.
- (a)
- (3)
A firm should also consider in relation to any overseas non-investment insurance product what is required to meet obligations under other rules in the FCA Handbook including, for example, the Principles and SYSC.
Meaning of ‘customer’ in PROD 4 for non-investment insurance contracts: consideration of policyholders, and policy stakeholders (including leaseholders)
Firms are reminded that in PROD 4, in relation to non-investment insurance contracts, as the context requires, ‘customer’ includes:
- (1)
a person who is a policyholder, or a prospective policyholder, whether or not they make the arrangements preparatory to the conclusion of the contract of insurance; and
- (2)
a policy stakeholder including a leaseholder.
For a non-investment insurance product that is or will be used to effect a multi-occupancy building insurance contract, when meeting the requirements under PROD 4, including in particular whether the product provides fair value for the purposes of PROD 4.2.14AR, a firm should consider the interests of:
- (1)
any policyholder making the arrangements preparatory to the conclusion of the contract of insurance;
- (2)
the freeholder and any other policyholder of the product; and
- (3)
PROD 1.5 Application of PROD 5
General: Who? What?
PROD 5 applies to a firm which:
- (1)
offers to sell an extended warranty to a customer; or
- (2)
refers, invites or induces a customer to obtain an extended warranty from a person connected to the firm;
in connection with the entering into of a rent-to-own agreement with the firm.
Where?
PROD 5 applies to a firm with respect to activities carried on from an establishment maintained by it, or its appointed representative, in the United Kingdom.
PROD 1.6 Application of PROD 6
- (1)
that manufactures or distributes pathway investments or default options in connection with its operating of a retail client’s personal pension scheme or stakeholder pension scheme;
- (2)
within the scope of PROD 4 when manufacturing pathway investments or default options, other than in connection with its operating of a retail client’s personal pension scheme or stakeholder pension scheme, as guidance with respect to that manufacturing activity;
- (3)
within the scope of PROD 3 when manufacturing pathway investments or default options, other than in connection with its operating of a retail client’s personal pension scheme or stakeholder pension scheme, as guidance with respect to that manufacturing activity.
PROD 1.7 Application of PROD 7
Application of PROD 7
A Gibraltar-based firm must also comply with the provisions in PROD 7 (Product governance: funeral plans).
Manufacturing a funeral plan product
The Glossary term ‘manufacture’ includes ‘designing, developing, creating and/or entering into or carrying out a funeral plan contract as provider’ which cover activities prior to the funeral plan product being approved for marketing and distribution, and on a continuing basis after such approval.
- (1)
For the purposes of PROD 7, a funeral plan intermediary is a manufacturer of a funeral plan product where an overall analysis of their activity shows that they have a decision-making role in designing and developing a funeral plan contract for the market.
- (2)
A decision-making role will be assumed, in particular, where a funeral plan intermediary autonomously determines the essential features and main elements of a funeral plan contract, including any of its price, costs, target market or guarantee rights, which are not substantially modified by the funeral plan provider.
- (3)
Personalisation of and adaptation of existing funeral plan products in the context of funeral plan distributions for individual customers, as well as the design of tailor-made contracts at the request of a single customer, are not manufacturing.
Territorial scope
PROD 7 applies to a firm with respect to activities carried on by it, or its appointed representative, in relation to:
- (1)
a funeral plan product; and
- (2)
Application of PROD 7
- (1)
PROD 7 applies to:
- (a)
a funeral plan provider; and
- (b)
with respect to:
- (c)
- (d)
- (a)
PROD 1.8 Application of PROD 8
PROD 8 applies to a firm that manufactures a product that is subject to the rules in:
(1) (in relation to insurance products) PROD 4 (Product governance: IDD and pathway investments);
(2) (in relation to financial instruments) PROD 3 (Product governance: MiFID); and
(3) (for any other product) PRIN 2A.3 (Consumer Duty: retail customer outcome – products and services).
PROD 8 supplements product manufacturer rules elsewhere in the FCA Handbook setting additional expectations where the product is available for distribution to recipients of targeted support services.
